Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.08% to 1,785.30 Indian rupees Monday, on what proved to be an ...

Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

Sun Pharmaceutical Industries Ltd. closed 12.97% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Campus placements at business schools face challenges due to changing job market dynamics and sectoral demands.

Two US nationals of Chinese-origin were pushed back from the Rangpo checkpost on March 9 it was found that they had entered Sikkim without proper clearances. Foreign nationals of Chinese origin ...

Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, Inc. for $4.10 per share, a 65% premium to last traded price, post-FDA approval of Unloxcyt for metastatic cutaneous ...

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal.

Sun Pharmaceuticals Industries Ltd. on Monday, March 10, said it will acquire a Nasdaq-listed immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc.

Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun Pharma’s oncology portfolio with FDA-approved UNLOXCYT for advanced cutaneous ...

The acquisition will be for an upfront cash payment of 4.10 dollars per share, aggregating up to 355 million dollars, the Sun Pharmaceutical Industries Ltd said on March 10. The deal, subject to ...